Hot Keywords
non-alcoholic fatty liver disease epidemiology microenvironment nonalcoholic steatohepatitis transplantation cholangiocarcinoma direct-acting antiviral immunotherapy hepatitis B hepatitis C liver resection imaging cancer stem cell diagnosis gene cirrhosis biomarker recurrence

Topic: Minimally Invasive Therapies for HCC: the Evidence and the Future

A special issue of Hepatoma Research

ISSN 2454-2520 (Online), ISSN 2394-5079 (Print)

Submission deadline: 15 Aug 2021

Guest Editor(s)

  • James O. Park, MD, FACS

    Chair of the Robotic Steering Committee; Clinical Director of Surgical Specialties for the WWAMI Institute for Simulation in Healthcare (WISH).

    Department of Surgery, University of Washington, Seattle, WA, USA.

    Center for Advanced Minimally Invasive Liver Oncologic Therapies (CAMILOT), University of Washington, Seattle, WA, USA.

    Website | E-mail

Submission Deadline

15 Aug 2021

Submission Information

Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to
For Online Submission, please login at
Submission Deadline: 15 Aug 2021
Contacts: Victoria Lee, Assistant Editor,

Published Articles

This special issue is now open for submission.
© 2016-2021 OAE Publishing Inc., except certain content provided by third parties